Left ventricular unloading with transaortic Impella 2.5 implantation in a pediatric patient supported by extracorporeal life support.
Impella implantation
extracorporeal life support
pediatric patients
Journal
Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
revised:
15
10
2020
received:
02
08
2020
accepted:
09
11
2020
pubmed:
14
11
2020
medline:
6
11
2021
entrez:
13
11
2020
Statut:
ppublish
Résumé
We report the case of a 12-year old female patient with Friedreich's ataxia and diabetes mellitus. Due to a progressive multiorgan failure, a veno-arterial extracorporeal membrane oxygenation was implanted through the axillary vessels. However, due to a lack of ejection and severe dilatation of the left ventricle, an Impella 2.5 was implanted. Due to the small diameter of the femoral arteries, we performed a trans-aortic implantation through a median sternotomy via a Dacron tube graft. We report on the procedure and perioperative outcome.
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
524-527Informations de copyright
© 2020 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation and Wiley Periodicals LLC.
Références
Ergle K, Parto P, Krim SR. Percutaneous ventricular assist devices: a novel approach in the management of patients with acute cardiogenic shock. Ochsner J. 2016;16:243-9.
Lauten A, Engström AE, Jung C, Empen K, Erne P, Cook S, et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail. 2013;6:23-30. https://doi.org/10.1161/CIRCHEARTFAILURE.112.967224
Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, et al. Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail. 2017;19:404-12. https://doi.org/10.1002/ejhf.668
Schmack B, Seppelt P, Weymann A, Alt C, Farag M, Arif R, et al. Extracorporeal life support with left ventricular decompression-improved survival in severe cardiogenic shock: results from a retrospective study. PeerJ. 2017;5:e3813. https://doi.org/10.7717/peerj.3813
Boll G, Fischer A, Kapur NK, Salehi P. Right axillary artery conduit is a safe and reliable access for implantation of Impella 5.0 microaxial pump. Ann Vasc Surg. 2019;54:54-9. https://doi.org/10.1016/j.avsg.2018.10.004
Schibilsky D, Lausberg H, Haller C, Lenglinger M, Woernle B, Haeberle H, et al. Impella 5.0 support in INTERMACS II cardiogenic shock patients using right and left axillary artery access. Artif Organs. 2015;39:660-3. https://doi.org/10.1111/aor.12529